Exhibit 5.1
| | |
| | 140 Scott Drive |
| | Menlo Park, California 94025 |
| | Tel: +1.650.328.4600 Fax: +1.650.463.2600 |
| | www.lw.com |
| | | | |
| |
![LOGO](https://capedge.com/proxy/S-1A/0001193125-21-026330/g63033g0128091809718.jpg) | | FIRM / AFFILIATE OFFICES |
| Beijing | | Moscow |
| Boston | | Munich |
| | Brussels | | New York |
| | Century City | | Orange County |
| | Chicago | | Paris |
February 3, 2021 | | Dubai | | Riyadh |
| | Düsseldorf | | San Diego |
| | Frankfurt | | San Francisco |
| | Hamburg | | Seoul |
| | Hong Kong | | Shanghai |
| | Houston | | Silicon Valley |
| | London | | Singapore |
| | Los Angeles | | Tokyo |
| | Madrid | | Washington, D.C. |
| | Milan | | |
Sana Biotechnology, Inc.
188 East Blaine Street, Suite 400
Seattle, Washington 98102
| Re: | Registration Statement No. 333-252061; Up to 25,300,000 shares of common stock of Sana Biotechnology, Inc. |
Ladies and Gentlemen:
We have acted as special counsel to Sana Biotechnology, Inc., a Delaware corporation (the “Company”), in connection with the proposed registration of up to 25,300,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share, including 3,300,000 shares pursuant to the exercise of the underwriters’ option to purchase additional shares of common stock. The Shares are included in a registration statement on Form S-1 under the Securities Act of 1933, as amended (the “Act”), initially filed with the Securities and Exchange Commission (the “Commission”) on January 13, 2021 (Registration No. 333-252061) (as amended, the “Registration Statement”). The term “Shares” shall include any additional shares of common stock registered by the Company pursuant to Rule 462(b) under the Act in connection with the offering contemplated by the Registration Statement. This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related prospectus, other than as expressly stated herein with respect to the issue of the Shares.
As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to General Corporation Law of the State of Delaware, and we express no opinion with respect to any other laws.